Genomic intelligence for clinical diagnostics and precision medicine development The Real-world Evidence to validate a drug target, identify trial-eligible patients, or change a diagnosis already exists. It is published. It is peer-reviewed. It is buried in 39 million biomedical articles, locked behind paywalls, hidden in tables, appendices, and supplemental datasets that most researchers and clinicians never find. Missing that evidence has consequences. Rare disease patients go undiagnosed. Cancer patients miss life-saving treatments built around variants their lab could not classify. Drug programs commit to development paths on incomplete data. Clinical trials miss eligible patients. Label expansions get left on the …

82 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: A.I.

Your personal healthcare assistant Cardiogram is building your personal healthcare assistant, using Deep Learning to turn consumer wearables—like the Apple Watch, Android Wear, and Garmin devices—into continuous health monitors that can be used to not only track sleep and fitness, but may one day prevent a stroke and save your life. We can now detect 4 medical conditions using consumer wearables: Sleep Apnea, High Blood Pressure, Atrial Fibrillation, and even Diabetes. We’ve been running clinical studies with UCSF Cardiology since 2016, have published in JAMA, NIPS, AAAI, and our work has been featured in the WSJ, Wired, CNBC, TechCrunch, and …

327 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I. A.I. - Deep Learning

The most complete picture of your health, made actionable Ahead Health is redefining preventive healthcare by making personalized health insights clear, actionable, and accessible anytime, anywhere. Our platform integrates your unique medical data—medical history, diagnostic images, extensive lab results—and uses advanced AI to derive new insights, to interpret the data, and to present the results in a way that’s both easy to understand and visually engaging. We started offering full-body MRI scans and blood tests bookable in Zurich, giving you a comprehensive baseline to proactively manage your health. Partnering with top medical providers, we focus on meaningful outcomes—helping you identify …

190 similar entities Type: Startup Activities: healthtech Technologies: A.I. Data Analytics

CardioSignal is developing a disruptive mobile application-based technology to improve the detection of heart disease. CardioSignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland and Palo Alto, CA, United States. The CardioSignal mobile application is a CE-marked class IIa medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well. CardioSignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology …

81 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Coala Heart Monitor System Coala Solutions is a medical technology and life science company focusing on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available to healthcare organizations to enable smart, digital cardiac assessments. CE and FDA cleared. We make it possible for everyone to monitor their heart. Cardiovascular diseases are one of the leading causes of death around the world. A key contributor is late diagnosis. Coala Life was founded as a …

72 similar entities Type: Startup Activities: healthtech deeptech Technologies: IoT

Know your patient, know your drug Genialis is a precision oncology company helping the most promising molecules become life-saving medicines. We are creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data. Data Fusion, Machine Learning, Biomedical Data Analysis, Omics Data Integration, …

103 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Data Analytics

Know what counts -- for the heart and blood vessels. The DGFF (Lipid League) e. V. was founded in October 1988 in Wiesbaden. Since June 27, 2024 it has been called the German Society for Lipidology. V. (DGFL) – Lipid League. At that time, the public controversy about the causes of hypercholesterolemia caused a stir and unsettled both the medical profession and the population. That's why scientists came together to make the discussions more objective. Today's DGFL (Lipid League) established itself as an independent contact for questions relating to lipid metabolism and atherosclerosis; it provides information and trains doctors to …

56 similar entities Type: SMB Activities: deeptech healthtech

Re-defining the way cardiovascular diseases are detected and treated with Artificial Intelligence (AI) Idoven is a European deep tech company advancing early detection and precision medicine for cardiovascular diseases. The Idoven AI platform, certified as EU MDR Medical Device Class IIa, delivers substantial improvements to the speed, consistency, scalability and accuracy of electrocardiogram (ECG) interpretation. Its powerful, proprietary AI model -Willem-, processes ECGs from almost any ECG device. Willem is also being used to develop new digital disease biomarkers towards patient identification, risk stratification and prognosis, as well as drug cardiac safety monitoring. Idoven partners with leading medical device and …

92 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I.

Promote cardiovascular health, promoting scientific knowledge and quality patient care. The SEC is a non-profit scientific and professional organization, dedicated to increasing the state of knowledge about the heart and circulatory system, to advance the prevention and treatment of their diseases, as well as to improve the survival and quality of life of cardiac patients. The objectives of the Spanish Society of Cardiology are the following: * Lead knowledge about cardiovascular conditions. * Contribute to international research, especially European and Latin American. * Create national and international links for the development of actions and the distribution of resources in cardiovascular …

24 similar entities Type: SMB Activities: biotech deeptech

Predictive Data to Preserve Health CardiaMetrics is a French medtech company based in Caen and Grenoble, dedicated to addressing the global epidemic of heart failure. Our ambition is clear: to maintain heart failure patients stable, prevent decompensation episodes, and reduce avoidable hospitalizations. We combine two breakthrough innovations: • A minimally invasive subcutaneous sensor that ensures reliable, continuous monitoring without requiring active patient engagement. • An artificial intelligence algorithm that provides healthcare teams with predictive intracardiac pressure dynamics — a clinically actionable hemodynamic biomarker enabling early therapeutic adjustments and personalized care. We work closely with leading hemodynamic experts to design robust …

182 similar entities Type: Startup Activities: healthtech deeptech Technologies: Data Analytics A.I.

A French liquid biopsy technology dedicated to the isolation of circulating tumor cells (CTCs) The number of cancer cases continues to rise worldwide, and detection is occurring earlier and earlier. In this context, precision medicine is no longer optional — it has become essential. Tailoring treatments to the specific characteristics of each patient is key to improving survival rates and quality of life. ScreenCell® is fully committed to this approach by developing single-use devices designed to isolate circulating tumor cells (CTCs) from a simple blood sample. Our liquid biopsy technology offers a non-invasive and cost-effective alternative for accessing valuable insights …

214 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Your ultimate personalized supplements. Clinically proven and backed by science. Innovative health tech company leading the way to the future of personalized health. Our proprietary biochemical database and patented technology allow us to design completely personalized solutions for health optimization. Recommended by world-leading medical institutions. Visit our site to learn more, and get started on your journey to better health! Health-tech, Digital, Data, and Bio-tech

714 similar entities Type: Startup Activities: healthtech Technologies: Data Analytics

Clinically actionable pharmacogenetics for personalized care. Abomics is a Finnish health technology company founded in 2013 by medical doctors that specializes in pharmacogenetics. We support healthcare professionals with pharmacogenetic solutions that enable precision medication. Pharmacogenetic testing helps identify more effective and safer medication and dosages, reducing trial-and-error prescribing and minimizing the risk of adverse drug reactions. Our solutions are designed to integrate seamlessly into clinical workflows bringing pharmacogenetic insights into everyday clinical decision-making. Built on scientific evidence and clinical expertise, we are a trusted partner to hospitals, laboratories, pharmaceutical companies, genomic service providers, and biobanks. Our PGx solutions: • Interpretation …

48 similar entities Type: Startup Activities: healthtech Technologies: SaaS

Building better healthcare for everyone. Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. Nightingale Health has developed the world’s most advanced health check for the health industry. Our solution provides risk detection for multiple chronic diseases from a single blood sample. Nightingale’s Health Check can be scaled to entire populations at a low cost, and it can replace many of the current risk assessments. Detecting disease risks on a population level allows for the effective targeting and tracking of health interventions, and better prevention of the onset of chronic diseases. With every sample we help to …

83 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Data Analytics

Ultromics is transforming the detection of heart failure using artificial intelligence for echocardiography. Ultromics pioneers precision heart failure detection. Our groundbreaking platform, EchoGo®, is revolutionizing the diagnosis of heart failure using artificial intelligence and cardiac ultrasound. Our technology empowers clinicians to make precise, efficient, and accurate assessments, drawing from the largest known heart disease dataset in echocardiography. We target challenging cardiac diseases, starting with HFpEF, to support timely diagnosis and early intervention. In collaboration with the Mayo Clinic, Johnson & Johnson, and Pfizer, we are continuously developing innovative diagnostic tools aimed at halting the progression of heart failure. Learn more: …

85 similar entities Type: Startup Activities: healthtech Technologies: A.I. A.I. - Machine Learning

Prédire pour prévenir - Bilans prédictifs permettant d'identifier le risque de maladies graves Pioneers of predictive medicine in France, we position ourselves as a player in 6P medicine: Predictive, Preventive, Personalized, Participative, Relevant, Multi-professional. After 14 years of research and development, Predilife obtained its medical device certification and began marketing predictive assessments: predictive breast cancer assessment, multi-pathology predictive assessments. At Predilife, we are passionate about serving health, a committed team that works every day to change the rules so that our motto "predict to prevent" is adopted by the greatest number of people. We accompany companies, healthcare professionals and employees …

66 similar entities Type: SMB Activities: deeptech manufacturing healthtech Technologies: Synthetic Biology

Unlocking the road to precision medicine in cancer care by tumor characterization via multiomics profiling and AI. Worldwide, there are more than 20 million new cases of cancer each year. First-line therapies are not always the most effective and there is a strong need to move towards personalized medicine by offering the patients the best treatment as quickly as possible. This will help in increasing the chance or cure. Therefore, there is a need to improve the prediction of the response to treatments to be able to save patient’s lives and reduce the cost of expensive inefficient treatments. Our goal …

186 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning

We help clients with their early detection and prevention of high-burden diseases using existing, routine EHR data. Medial EarlySign develops machine learning based decision support tools that expose the hidden layer of information in standard medical data. These new insights enable personal and outcome-based interpretation of medical data, yielding individualized predictions and treatment options for each patient, as well as early prediction of life-threatening conditions. Our cutting edge tools are designed to offer healthcare organizations a new way of looking at their data, empowering them with proactive, personalized and predictive care management capabilities. Medial EarlySign built and refined a unique …

123 similar entities Type: Startup Activities: healthtech Technologies: A.I. Data Analytics A.I. - Machine Learning

ExactCure's Digital Twin technology for personalized medication has become Biotrial Data Science ExactCure's Digital Twin technology for personalized medication has become Biotrial Data Science. ExactCure provides a personalized eHealth software solution. Our VISION is to live in a world where each individual has access to a personalized medication. Our MISSION is to predict the personalized effects and interactions of drugs within the body of each individual. Problem: Inappropriate medical treatments sometimes cause illness. This “iatrogenic” side effect leads to 20,000 deaths and costs €10 billion per year to the public healthcare system in France alone. Worldwide, it probably leads to …

198 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: A.I.

Precision medicine in cancer and rare diseases. Predictive/diagnostic tests/targeted therapies & innovative The French Society of Predictive and Personalized Medicine evaluates the medical benefit and good practices of genetic testing aimed at improving prevention and personalized treatments. It provides expert advice to health professionals and the general public through a transversal and multidisciplinary approach. The SFMPP publishes national and international recommendations on the use of genetic testing in the context of precision medicine.

60 similar entities Type: SMB Activities: healthtech deeptech biotech

AI-powered sleep apnea screening platform designed for cardiologists To make undiagnosed sleep apnea a thing of the past, because 80% of patients remain undiagnosed! 💤 Sleep apnea is a major cardiovascular risk factor, yet it often goes unnoticed. NOVIGA provides cardiologists with a medical software device for assessing sleep apnea syndrome using Holter ECG data. Our solution supports cardiologists in screening at-risk patients while integrating seamlessly into their daily practice. Inspired by the Esperanto word for “innovation,” NOVIGA embodies a deep commitment to bringing AI-powered digital solutions to the healthcare sector, and solutions designed to tackle the challenges of today’s …

91 similar entities Type: Startup Activities: healthtech Technologies: A.I.

We are recruiting 🇫🇷 🇬🇧 Satelia® is the French leader in remote medical monitoring of chronic heart failure, with more than 11,000 patients monitored every day in mainland France and overseas. Since 2017, he has designed digital medical devices and human services combining innovative algorithms and a patient-centered approach, in order to improve the quality of life of people suffering from chronic diseases. The only solution currently recognized by Health Insurance under a brand name and validated by the TELESAT-HF clinical study, Satelia® Cardio, combined with routine care, reduces mortality by 36% and hospitalizations by 17%, i.e. one death avoided …

402 similar entities Type: Startup Activities: healthtech Technologies: SaaS

Multiplex blood testing platform to monitor chronic diseases like heart failure Project co-funded by the European Union Founded in 2019, Omini is developing the first point-of-care blood biomarker monitoring platform to transform the lives of patients suffering from chronic diseases, using its unique multiplex electrochemical biosensor technology. Multiplexing provides personalized blood biomarker data that can be used to adjust therapies and prevent acute crises in patients with chronic conditions. The affordable device combines a portable reader and single-use test strips, similar to a glucometer, simultaneously measuring four to ten blood biomarkers from a single capillary blood sample. It can be …

183 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Data Analytics

We build patients’ Health Determinome for you. Increase the performance of your care and clinical research journeys NewClin develops a data-driven and AI-powered game-changing SaaS B2B platform to automatically contextualize patients' health data with their non-medical (social, behavioral, environmental) determinants of health. It allows the production of new patient-, cohort- and population-related predictive and prognostic markers, including a unique patient's Health Determinome, paving the way for precision interventions and precision prevention. Our ambition is to transform decisions from industry, healthcare providers, researchers, and payors in order to decrease the cost and increase the performance or healthcare and clinical research and …

261 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: A.I.

AI-powered preventive care that turns diabetes data into action-for patients, preventive providers,insurers and pharma. 537 million people live with diabetes. 6.7 million die from it every year. The global economic burden exceeds $966 billion annually, with complications driving 2.3x higher costs. And yet, most interventions still come too late — when the damage is already done. At MEROVA, we’re changing this. We built an AI-powered preventive ecosystem that tackles diabetes at its root — before complications develop, before costs escalate, before lives are lost. Every food choice reflected. Every blood sugar pattern understood. Every intervention recorded. Prevention isn’t just better …

142 similar entities Type: Startup Activities: healthtech Technologies: SaaS

Advancing cardiovascular care through science, innovation, and a commitment to better patient outcomes worldwide Amarin is a global pharmaceutical company committed to reducing the cardiovascular disease (CVD) burden for patients and communities and to advancing the science of cardiovascular care around the world. We own and support a global branded product approved by multiple regulatory authorities based on a track record of proven efficacy and safety and backed by robust clinical trial evidence. Our commercialization model includes a direct sales approach in the U.S. and an indirect distribution strategy internationally through a syndicate of reputable and well-established partners with significant …

190 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Genetic and medical tests: RT-PCR, antigen, non invasive prenatal test "Analyses and total medical care from home. Know the factors that affect your health"​ medmesafe was created as result of an observation and a belief. Our observation: Thanks to the advances in medicine and ICTs dealing with information processing (tests, medical imagery, genetic and genomic data,...) the probability of optimizing your health capital has never been as high as today. Our belief: To turn these virtual probabilities into real opportunities, it is necessary that everyone has access to the most accurate information regarding: - their specific health risks, - the …

96 similar entities Type: SMB Activities: deeptech healthtech Technologies: Data Analytics

Dispositif Médical Numérique de prise en charge à distance de l'insuffisance cardiaque chronique. CareLine is a multimodal remote monitoring solution for heart failure patients based on clinical, biological and therapeutic criteria. Patients are equipped with connected objects (weight scales, blood pressure monitors) to monitor their pathology at home and receive support and therapeutic education for their heart failure. Daily remote monitoring makes it possible to anticipate and detect a sudden worsening of the disease and also to ensure a rapid medical care. CareLine invests in research in collaboration with the IHU LIRYC of Bordeaux and the Institute of Cardiology of …

107 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

Personalized medicine from the 2D & 3D pharmaceutical printer IMPRINT: You can access our imprint by clicking on the “Find out more” button or at https://www.digital-health-systems.com/impressum. INNOVATOR OF THE YEAR 2023 https://www.youtube.com/watch?v=qF1H30U8_Ts DIHESYS – DIGITAL HEALTH SYSTEMS GMBH is an innovative, digital healthcare provider. ​We develop and manufacture information and process technology systems to give patients access to personalized medicines. ​With our products and services, we optimize patient healthcare in all areas (prevention, diagnostics, treatment and therapeutic success). We see a megatrend towards personalized medicine and the trend that patients want to take more and more responsibility for their personal …

47 similar entities Type: Startup Activities: deeptech Technologies: SaaS

The word of the heart Bits2beat Predictive Analytics is an information and medical technology company working to prevent stroke, a public health issue that remains unresolved today. It develops a SaMD (Software as a Medical Device) from data science applied to cardiology. Its innovative AI, for the acquisition and semantic interpretation of the heart rate, with any consumer connected device, disrupts the existing practice that is not ergonomic enough or efficient enough. It will allow screening of the main risk factors for stroke, including heart rhythm disorders, massively in the population at risk. cardiologie, logiciel médical, Software as a Medical …

117 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

Redefining Medicine A4M is dedicated to the advancement of tools, technology, and transformations in healthcare that can detect, prevent, and treat age-related diseases. A4M further promotes the research of practices and protocols that have the potential to optimize the human aging process. The organization is also dedicated to educating healthcare professionals and practitioners, scientists, and members of the public on biomedical sciences, breaking technologies, and issues related to the anti-aging industry. Our mission is to redefine modern medicine by providing clinicians with the education and resources needed to provide whole person care that optimizes healthspan and vitality for patients worldwide. …

100 similar entities Type: SMB Activities: biotech healthtech Technologies: Synthetic Biology

You will monitor your health with your nutrition. - https://iki-diag.com/informations-reglementaires-uriki/ IKI develops a home health lab for a personalized medical follow-up through simple and accurate urinary analyses. It is focused on the monitoring of lifestyle-related chronic diseases to provide better empowerment for Patients, remote monitoring tools for clinicians and cost-effective solutions for Payers. IKI a développé un laboratoire de santé à domicile, nommé URIKI, pour un suivi médical personnalisé grâce à des analyses urinaires simples, portables et précises. Il permet le suivi des maladies chroniques liées au mode de vie comme la maladie rénale chronique, les maladies cardio-vasculaires, les infections …

88 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Quality healthcare in your hands. Doktorconnect is a digital health platform that provides access to personalized medical care using a comprehensive wellness-based approach and genetic analysis for chronic disease prevention and management. We benchmark your genomics against your wellness result, to design an evidence-based lifestyle management plan for you. A digital platform that facilitates consultations with licensed doctors, both virtually and in person, using smart medical IoT devices for real-time vital signs tracking and remote patient monitoring. We also use breakthrough cognitive science methodologies and health coaching best practices to create healthy behaviors. We are solving the endemic problem of …

204 similar entities Type: Startup Activities: healthtech deeptech Technologies: SaaS

Better data for better care At the heart of Ad Scientiam's project is a conviction: measuring and monitoring the evolution of serious and disabling diseases on a continuous basis and in real life is essential for better management. We make visible these evolutions, until now undetectable, through the design and clinical validation of digital biomarkers. This scientific and technological challenge should enable each patient to be an active participant in their own illness and allow healthcare professionals to offer more individualized and therefore more efficient care. Ad Scientiam thus participates in the development of future treatments and in reducing the …

199 similar entities Type: Startup Activities: healthtech consulting it services Technologies: Data Analytics

XING Technologies has a clear vision in applying diagnostic nanotechnologies to globally enhance healthcare systems. We are an Australian-owned and operated cancer pathology lab that uses genetic sequencing to inform doctors and patients about precision cancer treatment options. Precision medicine offers cancer patients therapy options that are targeted specifically to their cancer. XING Genomic Services offers a range of cancer genetic tests for both newly diagnosed cancer patients and patients dealing with a recurrence of their disease. The results analysed in our lab will determine whether the genetic alterations found in your cancer match genetic changes that are associated with …

65 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We prevent the preventable with medical AI solutions We prevent the preventable with medical AI solutions. The key to diagnostic medicine lies in the use of algorithms. We aim to provide healthcare institutions with data on individual risks that have been analyzed in advance, allowing the institutions to provide healthcare to their patients based on data science. For this reason, we continue to develop an artificial intelligence learning model with excellent performance through insights and research from experts in the field to prevent major severe diseases. This, in turn will help increase the patients' awareness and screening efficiency of screening …

220 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I. A.I. - Deep Learning A.I. - Machine Learning

Solving chronic disease with the world's leading precision medicine AI. We're addressing one of the greatest challenges of our time - transforming healthcare to predict, treat, and prevent the world's most costly diseases. Chronic diseases are the biggest challenge facing global health. Billions of people live with debilitating conditions that are misunderstood, misdiagnosed, and mistreated - crippling healthcare systems, limiting quality of life, and costing trillions of dollars around the world. PrecisionLife is here to change that. We've developed the world's leading AI and genetic analysis platform on the planet to decipher the biological drivers of complex conditions and solve …

69 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology

Helping people with rare genetic diseases get answers. Probably Genetic helps undiagnosed rare disease patients find answers to their symptoms in a matter of weeks. There are over 400 million people worldwide that have a rare disease — more than cancer and HIV patients combined. Half of those patients are currently undiagnosed and half of them are children, and it takes 5-7 years on average for these patients to get a diagnosis. With our system, patients can get answers in a matter of weeks. Our online Symptom Checker identifies rare disease patients using state-of-the-art machine learning models, gets them tested …

61 similar entities Type: Startup Activities: insurtech deeptech Technologies: Synthetic Biology

Prescription digital therapeutics powered by personalized nutrition. Reimagining medicine At Perfood, we translate state-of-the-art data and medical science into therapy. We create software, that precisely identifies what actions need to be take on a personalized level, to prevent or fight diseases. Using sensors, lab results and holistic analyses, we derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. We call this approach digital therapeutics. A digital solution that is just as effective as a drug. But without side effects. We believe that our genetic heritage is an elementary compound of our health. …

101 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Opening a new frontier in the fight against atherosclerosis PlaqueTec is pursuing a better understanding of the biological mechanisms of coronary artery disease (CAD) to advance the development of precision medicine. CAD, where atherosclerotic plaque build-up narrows or blocks the arteries that supply blood to the heart, is a leading cause of death globally. Current treatment approaches are one-size-fits-all and therefore ineffective for many patients. To address this, PlaqueTec has developed a proprietary technology and data analysis platform to endotype patients and uncover potential biomarkers of coronary vascular function and plaque progression. A more detailed understanding of patient endotypes will …

88 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transforming diagnosis through gynecological fluids At MiMark, we believe that diagnosing a disease should never add more suffering to patients. That’s why we’ve developed a revolutionary diagnostic approach that uses gynecological fluids to diagnose gynecological diseases efficiently and accurately. Our mission is clear: to make gynecological diagnosis simpler, safer, and more human – for patients, clinicians, and healthcare systems alike. *Disease is complicated. Diagnosis shouldn't be.* For decades, women's health has been underestimated in research and diagnostics.Existing tests for gynecological diseases are often invasive, painful, costly, and sometimes inconclusive. At MiMark, we are changing that reality by developing protein-based diagnostics …

79 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Empowering the next generation of clinical genomics: Monogenic + Polygenic Allelica develops clinical Polygenic Risk Score (PRS) tests to prevent cardiovascular disease and cancer. Our diagnostics are used by leading healthcare institutions in the US and internationally to identify high-risk individuals who benefit from personalized prevention and screening plans. We also operate through a decentralized model, enabling clinical genetics laboratories to develop and deliver their own PRS-based diagnostics with confidence. Working with leaders in the field, such as Baylor College of Medicine, we have set the industry standard for developing clinical PRS tests, ensuring quality and regulatory compliance at every …

125 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics

Enabling the future of personalized healthcare with patient-generated insights. Personalized health needs patient insights. Most of a patient's journey remains unobserved and hidden in unknowledge, for both patients and healthcare providers. TOM sheds light on the dark and generates knowledge about the therapeutic process. With millions of proprietary, patient-generated data. The TOM App boasts world-class patient engagement, fostering behavior change and adherence for superior therapy outcomes. patient-generated therapy data, personalized healthcare, Real-World-Evidence, Digital Health, Patient-Safety, Communications Platform Provider, Multidirectional Communications for health and medical experts, Pharmacovogilance, Saas-Solution for Pharma & Biotech Companies, PROs & PROMs, Patient generated Insights, Medication Management, …

75 similar entities Type: Startup Activities: healthtech Technologies: Data Analytics

DNA-based Digital Twin to help predict and prevent diseases and adverse reaction to drugs Personal genomics solution for predictive medicine—Thanks to unique and groundbreaking technology, Predictiv identifies the genetic predispositions of an individual on 22,000+ diseases and simulated reactions to 750+ drugs. Now enabling more accurate preventive actions and treatments. genomics, predictive medicine, preventive medicine, heathcare, and biotechnology

150 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Advanced heart failure monitoring in a simple step. Bodyport is on a mission to empower every person to live free from complex chronic conditions — by delivering actionable insights gleaned from unique health signals and simple, at-home experiences. We’re advancing the standard of care for complex chronic conditions like heart failure. By integrating a sophisticated biomarker platform into simple, easy-to-use devices, we help patients and their care teams better predict, understand, and intervene in changes to heart health — keeping people healthier and out of the hospital. With one simple step, our platform noninvasively measures a broad spectrum of hemodynamic …

83 similar entities Type: Startup Activities: healthtech Technologies: SaaS

The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class: BAPAIs for BrainAminopeptidase A Inhibitors. We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure. High blood pressure remains a major public health concern. Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A. The mid-term strategic objective of the company is to …

62 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Award-winning company empowering patients through gold-standard rapid diagnostics Our mission is to revolutionise the field of diagnostics by providing rapid, accurate, and quantified point-of-care testing solutions. We strive to empower healthcare professionals with advanced technologies that enhance speed-to-care, leading to improved patient outcomes and ultimately saving lives. What We Have Delivered - A significant pipeline of tests currently focused on the most important global health challenges: Post-viral syndromes like Long Covid, COVID-19, Liver Health, Diabetes, Obesity, and Antimicrobial Resistance (AMR). Currently the Company’s Long Covid research test is available in the UK, Switzerland, Cyprus with plans to roll out in …

281 similar entities Type: Startup Activities: deeptech healthtech Technologies: Data Analytics

Prevention means taking care of your health when everything is going well. We offer a new approach to taking care of your health. Suriia supports individuals in the prevention and screening of diseases such as cancer, cardiovascular and mental illnesses. Thanks to an exhaustive questionnaire, we analyze each user's exposome, their risk factors and their lifestyle habits. Our advanced algorithms show each individual the diseases they are likely to be exposed to and provide recommendations to reduce these risks. On this basis, we develop personalized prevention and screening programs, including suggestions for medical examinations to be carried out. Once these …

84 similar entities Type: Startup Activities: healthtech Technologies: Cybersecurity

Advancing Diagnostics to the Point Of Care Genedrive Diagnostics Ltd is a pharmacogenetic testing company developing and commercialising a rapid and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare. Pharmacogenetics informs on how your individual genetics impact a medicines ability to work for you. Therefore, by using pharmacogenetics, medicine choices can be personalised, made safer and more effective. The Company has launched its two flagship products, the Genedrive® MT-RNR1 ID Kit and the Genedrive® CYP2C19 …

58 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Love your DNA 🧬 Genetic progress in recent years is only comparable to the advancements in the field of computer science. Our vision is to enable everyone to learn about their unique genetic code and inspire new ideas and scientific approaches. Since the completion of the human genetic code in 2003, the number of studies and sources of information on genetic markers, along with the scientific drive to better understand the genotype-phenotype has grown exponentially. In ADNTRO we help you navigate all present & future findings. Invest in your DNA – its for Life. GWAS, Genetics, Education, bioinformatics, Polygenic risk …

88 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. - Machine Learning

Award-winning precision health platform delivering personalized wellness solutions through genomics and deep science. LifeNome is a global leader transforming personalized health through AI, genomics, and multi-omics. Serving over 650,000 individuals across 15+ countries, our precision platform delivers science-backed wellness and preventive care solutions for the healthcare, insurance, and pharmaceutical sectors. Our Core Solutions: Precision Prevention: AI-driven disease risk detection and intervention. Maternal & Family Health: Personalized fertility, prenatal, and postpartum care. Biological Longevity: Programs focused on extending healthy lifespan. Personalized Nutrition: Data-driven wellbeing based on genomic insights. Recognized by the World Economic Forum, PepsiCo, and Abbott, we empower Fortune 500 …

109 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I.

BiogeniQ helps people optimize their nutrition and medication based on their genetic composition. We allow everyone to access important portions of their DNA, while providing a useful tool for healthcare professionals. We put emphasis on solid, peer-reviewed research and integration of our genetic reports into future healthcare. Médecine Personnalisée, Dépistage Génétique, Nutrigénomique, Pharmacogénétique, Génotypage, and Génomique

69 similar entities Type: Startup Activities: biotech deeptech

Excellence for Life BIOTRONIK is a global medical device company providing products and services for the treatment of cardiovascular and endovascular diseases. Patient well-being is our main priority. For 60 years, we have been driven by the desire to save lives and improve the quality of life of patients. With thousands of employees in more than 100 countries, we are among the world's leading medical technology innovators in the areas of cardiac rhythm management, electrophysiology and vascular intervention. Our technology empowers doctors around the world to provide their patients with the best possible healthcare. Heart rate management Implantable devices help …

140 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

The future of biomonitoring. Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care, has the potential to sense changes in well-known biomarkers used already to monitor patients with chronic cardiac and respiratory diseases. However, they need to be measured in blood, which limit their use only in medical institutions. Our non-invasive products based on wearable formats will empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter …

238 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Cardiomo provides wearable remote cardiac monitoring using a proprietary AI engine to enable early warnings in real time Cardiomo is a miniature wearable patch for continuous, real-time, remote health monitoring to detect and predict medically actionable CVD events and push alerts to save lives. The patch has sensors to record ECG, Respiration, Skin Temp and Body Movement. A Mobile app registers vitals with body motion and position; this data is analyzed by our AI Engine in a HIPAA compliant cloud to detect CVD symptoms. The end-user app shows consumer friendly info such as Pulse, HRV and various health scores based …

93 similar entities Type: Startup Activities: healthtech Technologies: A.I. IoT Sensors

CE-, FDA- & TGA-approved medical app capable of detecting heart rhythm disorders FibriCheck is an innovative digital health company dedicated to transforming the way cardiac care is delivered. We do so by providing a medically certified, software-only and device-agnostic solution that redefines the way cardiac arrhythmias are detected and managed. We empower people to take control of their heart health by offering them our PPG-technology in a user-friendly setting. Users can measure their heart rhythm in 60 seconds, using the camera of their smartphone without any additional hardware. These measurements provide valuable insights into the heart rhythm which help people …

172 similar entities Type: Startup Activities: deeptech healthtech it services Technologies: Data Analytics

Genetics is advancing at a rapid pace, transforming research and revolutionising the way we diagnose and treat complex diseases such as heart disease and cancer. We are a team of scientists and developers specialised in genetics and bioinformatics, determined to increase access to genomic medicine in the clinic. We develop innovative solutions to make genomic medicine more accessible, partnering with a portfolio of private and public laboratories in the UK and overseas. Our approach is strongly shaped by our scientific background and experience. Our flexible, powerful online ordering platform for genetic tests enables clinicians to find and order tests for …

129 similar entities Type: Startup Activities: biotech deeptech Technologies: SaaS

Decisive Coronary Care. Heartflow is the global leader in AI-driven coronary artery disease (CAD) management, transforming how CAD — the world’s leading cause of death — is diagnosed and treated. Our advanced technology generates personalized, precision 3D heart models from a single CT scan, providing clinicians with the clarity and confidence to deliver earlier, more effective treatments — transforming CAD into a disease that can be managed for life. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed coronary CTA pathway. The AI-driven platform — including RoadmapTM Analysis, FFRct Analysis and Plaque …

87 similar entities Type: Startup Activities: healthtech manufacturing deeptech Technologies: A.I. - Deep Learning A.I.

Making personalized healthcare possible for individuals, healthcare providers, benefit administrators and employers. Pharmacogenomics (PGx) is the next frontier in medication therapy management and RxGenomix was created specifically to help put it to work for everyone. RxGenomix helps healthcare providers understand the genetic-driven mechanisms behind the response to medications and navigate the implementation process of a new healthcare tool. By applying PGx testing, they can look at very specific pieces of their patients’ DNA to know, for many of the most common and critical medications, precisely which might be best for that individual, and at what dosage. Empowering healthcare providers with …

52 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Unique technology and novel data for personalized and optimal treatment of high cholesterol MONCYTE Health has a unique proprietary technology to quantify individual differences in cellular lipid uptake and storage which contribute to high blood cholesterol and the effectiveness of common lipid-lowering drugs. The readouts are derived from white blood cells, including monocytes, which play key roles in atherosclerotic plaque formation and inflammation, linking directly to cardiovascular risk. Precisely quantifying these individual differences enables personalized treatment strategies in combination with risk assessment which can help patients more effectively achieve optimal blood cholesterol levels faster, and thereby reduce the risk for …

66 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics Synthetic Biology

Leave no patients undiagnosed Health in Code is a leading biotechnology company with a clear mission: to identify health conditions that can benefit from genetic diagnosis and to develop and deliver advanced genetic testing services and products to support precision medicine. Since our foundation, our hallmark has been the integration of cutting-edge knowledge management systems with a highly specialized, multidisciplinary team. This synergy allows us to offer unmatched expertise in the interpretation of genetic data, delivering results that go beyond genotyping — we provide clinically meaningful insights. With a strong international outlook rooted in years of clinical and research experience, …

116 similar entities Type: SMB Activities: biotech deeptech Technologies: Data Analytics